Cargando…

Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study

OBJECTIVES: To compare the epidemiology of paediatric and adult patients receiving rabies immune globulin (RIG). DESIGN: Cross-sectional prevalence study. SETTING: Eligible participants from the Symphony Integrated Dataverse presenting between 2013 and 2019. PARTICIPANTS: All adult and paediatric pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Burke, Rita V, Russo, Pierantonio, Sicilia, Michael, Wolowich, William, Amega, Novinyo, Nguyen, Huy-Binh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045048/
https://www.ncbi.nlm.nih.gov/pubmed/35473745
http://dx.doi.org/10.1136/bmjopen-2021-055411
_version_ 1784695226759118848
author Burke, Rita V
Russo, Pierantonio
Sicilia, Michael
Wolowich, William
Amega, Novinyo
Nguyen, Huy-Binh
author_facet Burke, Rita V
Russo, Pierantonio
Sicilia, Michael
Wolowich, William
Amega, Novinyo
Nguyen, Huy-Binh
author_sort Burke, Rita V
collection PubMed
description OBJECTIVES: To compare the epidemiology of paediatric and adult patients receiving rabies immune globulin (RIG). DESIGN: Cross-sectional prevalence study. SETTING: Eligible participants from the Symphony Integrated Dataverse presenting between 2013 and 2019. PARTICIPANTS: All adult and paediatric patients with integrated claims and demographic data associated with RIG use from the Symphony Integrated Dataverse from 2013 to 2019. PRIMARY AND SECONDARY OUTCOME MEASURES: Prevalence of diagnoses and procedures associated with paediatric and adult patient population based on frequency of International Classification of Diseases (ICD-9/ICD-10) and Current Procedural Terminology codes, respectively. METHODS: We used mutual information to identify features that differentiate the paediatric from adult patient population. Prevalence ratios were calculated to compare adult and paediatric patients. RESULTS: There were 79 766 adult and 20 381 paediatric patients who met the inclusion criteria. Paediatric patients had a 5.92-fold higher prevalence of ‘open wounds to the head; neck; and trunk’, 3.10-fold higher prevalence of ‘abrasion or friction burn of face; neck; and scalp except eye; without mention of infection’, 4.44-fold higher prevalence of ‘open wound of scalp; without mention of complication’ and 6.75-fold higher prevalence of ‘laceration of skin of eyelid and periocular area | laceration of eyelid involving lacrimal passages’. Paediatric patients had a 3.83-fold higher prevalence of complex repairs compared with adult patients (n=157, 0.7% vs n=157, 0.2%, respectively). CONCLUSIONS: Paediatric patients represent a significant proportion of the patient population receiving RIG, and are associated with higher prevalence of codes reporting repair of larger, more complex wounds in highly innervated anatomical regions. Dosing and administration of RIG must be informed by animal bite wound characteristics; clinicians should understand the differences between presentations in adults and children and treat accordingly.
format Online
Article
Text
id pubmed-9045048
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-90450482022-05-11 Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study Burke, Rita V Russo, Pierantonio Sicilia, Michael Wolowich, William Amega, Novinyo Nguyen, Huy-Binh BMJ Open Epidemiology OBJECTIVES: To compare the epidemiology of paediatric and adult patients receiving rabies immune globulin (RIG). DESIGN: Cross-sectional prevalence study. SETTING: Eligible participants from the Symphony Integrated Dataverse presenting between 2013 and 2019. PARTICIPANTS: All adult and paediatric patients with integrated claims and demographic data associated with RIG use from the Symphony Integrated Dataverse from 2013 to 2019. PRIMARY AND SECONDARY OUTCOME MEASURES: Prevalence of diagnoses and procedures associated with paediatric and adult patient population based on frequency of International Classification of Diseases (ICD-9/ICD-10) and Current Procedural Terminology codes, respectively. METHODS: We used mutual information to identify features that differentiate the paediatric from adult patient population. Prevalence ratios were calculated to compare adult and paediatric patients. RESULTS: There were 79 766 adult and 20 381 paediatric patients who met the inclusion criteria. Paediatric patients had a 5.92-fold higher prevalence of ‘open wounds to the head; neck; and trunk’, 3.10-fold higher prevalence of ‘abrasion or friction burn of face; neck; and scalp except eye; without mention of infection’, 4.44-fold higher prevalence of ‘open wound of scalp; without mention of complication’ and 6.75-fold higher prevalence of ‘laceration of skin of eyelid and periocular area | laceration of eyelid involving lacrimal passages’. Paediatric patients had a 3.83-fold higher prevalence of complex repairs compared with adult patients (n=157, 0.7% vs n=157, 0.2%, respectively). CONCLUSIONS: Paediatric patients represent a significant proportion of the patient population receiving RIG, and are associated with higher prevalence of codes reporting repair of larger, more complex wounds in highly innervated anatomical regions. Dosing and administration of RIG must be informed by animal bite wound characteristics; clinicians should understand the differences between presentations in adults and children and treat accordingly. BMJ Publishing Group 2022-04-25 /pmc/articles/PMC9045048/ /pubmed/35473745 http://dx.doi.org/10.1136/bmjopen-2021-055411 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Epidemiology
Burke, Rita V
Russo, Pierantonio
Sicilia, Michael
Wolowich, William
Amega, Novinyo
Nguyen, Huy-Binh
Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
title Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
title_full Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
title_fullStr Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
title_full_unstemmed Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
title_short Epidemiology of rabies immune globulin use in paediatric and adult patients in the USA: a cross-sectional prevalence study
title_sort epidemiology of rabies immune globulin use in paediatric and adult patients in the usa: a cross-sectional prevalence study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045048/
https://www.ncbi.nlm.nih.gov/pubmed/35473745
http://dx.doi.org/10.1136/bmjopen-2021-055411
work_keys_str_mv AT burkeritav epidemiologyofrabiesimmuneglobulinuseinpaediatricandadultpatientsintheusaacrosssectionalprevalencestudy
AT russopierantonio epidemiologyofrabiesimmuneglobulinuseinpaediatricandadultpatientsintheusaacrosssectionalprevalencestudy
AT siciliamichael epidemiologyofrabiesimmuneglobulinuseinpaediatricandadultpatientsintheusaacrosssectionalprevalencestudy
AT wolowichwilliam epidemiologyofrabiesimmuneglobulinuseinpaediatricandadultpatientsintheusaacrosssectionalprevalencestudy
AT ameganovinyo epidemiologyofrabiesimmuneglobulinuseinpaediatricandadultpatientsintheusaacrosssectionalprevalencestudy
AT nguyenhuybinh epidemiologyofrabiesimmuneglobulinuseinpaediatricandadultpatientsintheusaacrosssectionalprevalencestudy